A 21 CFR Part 11 compliant ELN is an electronic lab notebook built to the FDA standard for trustworthy electronic records and signatures. It captures a time-stamped audit trail of every change, binds electronic signatures to the records they approve, enforces unique per-user access, and carries the validation evidence an inspector expects.
The capability comes from the platform. Whether your deployment is compliant depends on how you configure and validate it. Every vendor will call their product Part 11 ready. That is fair for the software, but compliance is a property of the configured system your lab runs, and the gap between those two things is where audits fail.
What 21 CFR Part 11 requires of an electronic record system
21 CFR Part 11 is the FDA regulation defining how electronic records and signatures have to work to count as trustworthy and equivalent to paper. It applies whenever electronic records replace paper records an FDA predicate rule requires. If a GxP rule says you must record an observation or sign a result and your ELN is where that happens, Part 11 is in scope. Our guide to what your lab software needs for 21 CFR Part 11 covers the regulation in full; this article focuses on the ELN.
For an ELN, the requirements land in five places:
- A secure, computer-generated, time-stamped audit trail of record creation and change
- Electronic signatures bound to their records, carrying the signer, the time, and the meaning of the signing
- Access controls that tie every action to a unique, identified user
- Data integrity controls that keep records attributable, original, and accurate over their full retention period
- Validation evidence that the system performs as specified, plus change control that keeps it valid
The audit trail requirement and how ELNs handle it
The audit trail is the part of Part 11 ELN buyers underestimate, and the part inspectors check first. A compliant trail records the original value, the new value, who made the change, when, and why, for every regulated record. It has to be computer-generated, time-stamped, and independent: the person who edits a result cannot edit or delete the entry that logs the edit. The eCFR text of Part 11 has the exact wording.
In a well-built ELN this is structural. Entries are versioned, edits are appended rather than overwritten, and the prior version stays readable. Change a value from 5.2 to 5.3 and the system keeps both numbers, stamps the change with the user and time, and requires a reason before accepting it. Benchling and LabArchives build this in at the data layer, so the trail cannot be switched off for one entry or cleaned up later.
Two things separate a trail that passes from one that does not: whether the reason for change is captured at the moment of editing, and whether the trail is human-readable when an inspector pulls it. A raw event log full of database keys proves nothing to an auditor. We have written on why labs need readable audit records, and it applies here.
When you evaluate an ELN, do not just confirm a trail exists. Edit a test record and ask the vendor to show the entry exactly as an FDA inspector would see it, including the reason-for-change prompt and the readable export. If the demo is awkward, the audit will be too.
Electronic signatures and what counts as compliant under Part 11
A compliant electronic signature does three things: it identifies the signer by printed name, stamps the date and time, and states the meaning of the signature, whether authorship, review, or approval. That meaning is recorded and travels with the record when it prints or exports.
For non-biometric signatures, Part 11 requires two identification components, normally a user ID and password. The catch is timing. A user cannot sign by clicking a button while logged in; they re-enter credentials at the moment of signing. Benchling requires this before an entry is signed, and once signed the entry locks to read-only. A signature that does not freeze the record it signs protects nothing.
Witness and countersignature workflows matter for GLP labs. LabArchives builds in signing and witnessing so a second qualified person can review and countersign, mirroring paper practice. When comparing platforms, check that the signature meaning options match your SOPs and that a signed record cannot be edited without a new, audited version.
Access controls and user accountability
Every requirement above assumes the system knows who did each thing. A compliant ELN gives each person a unique account, ties every entry and signature to it, and never allows shared logins. The moment two researchers share a credential, attributability collapses and the audit trail stops meaning anything.
Role-based access is the mechanism. Authors create and edit, reviewers approve, QA reads across projects, and administrators manage users without altering scientific records. Segregation of duties keeps the author of an entry separate from its approver where your process requires it. Deactivation has to be immediate when someone leaves, and periodic access reviews keep the permission list honest.
Data integrity and the ALCOA+ principles in an ELN
Part 11 defines the controls; ALCOA+ defines the outcome they protect. It is the data integrity framework the FDA uses to inspect records, set out in its 2018 data integrity guidance. The nine attributes, and what each asks of an ELN:
- Attributable: every record traces to a named person, through unique accounts and signed entries.
- Legible: records and audit trails stay readable for the full retention period, not locked in an obsolete format.
- Contemporaneous: data is recorded when the work happens, with system timestamps the user cannot backdate.
- Original: the ELN holds the original record or a verified true copy, with versions preserved rather than overwritten.
- Accurate: values are correct and free from unrecorded edits, with every change captured in the trail.
- Complete: nothing is deleted, including failed runs and repeated tests; the trail shows the full history.
- Consistent: events are sequenced and time-stamped in order, across time zones and instruments.
- Enduring: records survive on durable media for their required lifetime, through backups and archival.
- Available: records can be retrieved and read on request, including during an inspection.
An ELN that handles the five Part 11 controls well satisfies much of ALCOA+ as a byproduct, since the same audit trail, signature, and access mechanisms produce attributable, original, and accurate data. Enduring and Available need separate attention, because they depend on archival and retention design rather than daily notebook features. Exportability belongs here too: if you ever move off the platform, the cost of lab software data lock-in lands hardest on records you cannot cleanly extract.
Validation packages: what to ask an ELN vendor for
Choosing a Part 11 compliant ELN does not satisfy the validation requirement, which surprises buyers. The FDA expects documented evidence the system performs as specified before regulated use, split between the vendor and you. The vendor validates the core product. You validate your configuration, roles, signature workflows, and integrations, and you hold that state through every upgrade.
The GAMP 5 framework sets the risk-based approach. A configurable commercial ELN needs less validation effort than custom software, since the vendor has qualified the core, so your work concentrates on configuration and extensions. What you want from the vendor is documentation that lets you stand on their qualification instead of redoing it.
Ask every shortlisted vendor for:
- Validation support packages, including IQ, OQ, and PQ templates and test protocols you can execute or adapt
- A traceability matrix linking Part 11 requirements to system features and the tests that exercise them
- Their own audit or qualification reports for the infrastructure and core product, especially for a cloud platform
- Release notes that carry a validation impact assessment, so you can judge what each upgrade means for your validated state
- A separation between security patches and feature releases, so you can take critical fixes without revalidating new functionality
A vendor that hands you a complete validation package shortens your project by months. One that expects you to build it yourself is moving the cost onto your QA team, whether or not it shows up on the quote.
Cloud ELN versus on-premise ELN for 21 CFR Part 11 compliance
A cloud ELN can be fully Part 11 compliant. Cloud systems are not exempt from the regulation and not disqualified by it, a misconception that still kills good options in procurement meetings. What changes between cloud and on-premise is who runs the infrastructure and how upgrades arrive, not whether compliance is possible.
With cloud, the vendor qualifies the infrastructure, manages backups and availability, and supplies the platform validation documentation. Benchling packages this as a Validated Cloud tenancy separate from its standard one, which is the distinction that matters: the compliant capability lives in a specific tier. The trade is upgrade cadence, since the vendor controls the schedule, so you want sandbox access and validation-impact release notes.
With on-premise, you control timing and infrastructure but carry the qualification work the cloud vendor would otherwise do, from server validation to backup verification to upgrade testing. For a lab without a standing IT and validation team, that burden is heavier than it looks.
| Consideration | Cloud ELN | On-premise ELN |
|---|---|---|
| Infrastructure qualification | Vendor handles and documents it | Your team owns and documents it |
| Validation documentation | Vendor supplies platform package; you validate configuration | You build most of the package |
| Upgrade control | Vendor schedules; you validate impact | You schedule and validate on your timeline |
| Best for | Labs that want compliance support and lower IT overhead | Labs needing full control over timing, data residency, or air-gapped deployment |
How major ELN vendors handle 21 CFR Part 11
The take that matters more than any feature list: compliant capability and a compliant deployment are two different purchases. Every vendor below publishes Part 11 and EU Annex 11 support, and the features look similar because the regulation is the same. They differ in how compliance is packaged, which tier carries it, and how much validation documentation comes with the contract.
Here is how four of the most widely used regulated ELN platforms position their Part 11 support:
| Vendor | Part 11 positioning | Where compliance lives |
|---|---|---|
| Benchling | Audit trail, version control, and credential-gated electronic signatures aligned to Part 11 and Annex 11 | The Validated Cloud tenancy, distinct from standard tenancy |
| Revvity Signals | Electronic signatures, audit trails, and a dedicated validation-readiness program for Signals Notebook | The Signals Notebook cloud, with validation-readiness packages for regulated use |
| IDBS | GxP cloud with audit trails, electronic signatures, and ALCOA++ data integrity, built for big-pharma R&D and manufacturing | The GxP edition of E-WorkBook and Polar |
| LabArchives | Tamper-evident audit trails, automatic timestamping, and a signing-and-witnessing workflow | GxP and FedRAMP-authorized government editions, alongside the academic product |
The right ELN depends on the science you run, the systems you already own, and which tier carries the validated capability; our guide to choosing a lab software approach walks through that selection. Before signing, confirm the price you are quoted covers the compliant configuration and not a lighter tier that drops the controls you need.
Conclusion
An ELN meets 21 CFR Part 11 by getting five things right: an independent audit trail, bound electronic signatures, unique-user access, ALCOA+ data integrity, and validation that survives every upgrade. The platform supplies the capability; your configuration, validation, and change control decide whether the running system is compliant, and that is what an inspection examines. Push past the marketing claim and look at the audit trail an inspector would read, the validation package you would inherit, and the tier that carries the controls. Treat Part 11 as a design constraint, not a label you buy.
Choosing or validating an ELN for a regulated lab? CodePhusion builds and integrates 21 CFR Part 11 compliant LIMS and ELN systems for biotech and life sciences teams, including the audit trail, signature, and validation work that keeps them inspection-ready. to talk through your requirements.
Frequently Asked Questions
How do electronic lab notebooks support FDA 21 CFR Part 11 compliance?
An ELN supports 21 CFR Part 11 by capturing a secure, computer-generated, time-stamped audit trail of every change, binding electronic signatures to the records they approve, enforcing unique per-user access with no shared logins, and producing validation evidence that the system works as specified. The platform provides these capabilities; the lab still has to configure and validate the system for its own use.
What makes an ELN 21 CFR Part 11 compliant?
A 21 CFR Part 11 compliant ELN has an independent, tamper-evident audit trail, electronic signatures that capture the signer's name, the date and time, and the meaning of the signature, two-component authentication at the moment of signing, role-based access controls tied to unique accounts, and a documented validation package. Compliance is a property of the configured and validated deployment, not of the software in the abstract.
Is a cloud ELN 21 CFR Part 11 compliant?
A cloud ELN can be fully 21 CFR Part 11 compliant. Cloud systems are not exempt from Part 11 and they are not disqualified by it. The vendor handles infrastructure qualification and supplies validation documentation, while the lab still owns user-level controls, signature workflows, and validation of its own configuration. The main differences from on-premise are who runs the infrastructure and how upgrades are scheduled and validated.
What audit trail features does Part 11 require in an ELN?
The audit trail must record the original value, the new value, who made the change, when, and why, for every regulated record. It must be computer-generated, time-stamped, and independent, meaning a user cannot edit or delete their own audit entries. It has to be retained as long as the underlying records and be available in human-readable form for an inspector to review.
Which ELN platforms are 21 CFR Part 11 compliant?
Benchling, Revvity Signals, IDBS, and LabArchives all publish 21 CFR Part 11 and EU Annex 11 capabilities including audit trails and electronic signatures. The published feature list is the starting point. What matters for a purchase is whether the specific tier and configuration you are buying is the validated one, and what validation documentation the vendor will hand over.
Do you still need to validate a Part 11 compliant ELN?
Yes. Buying an ELN marketed as Part 11 compliant does not satisfy the validation requirement. The vendor validates the core product, but the lab has to validate its own configuration, user roles, signature workflows, and integrations, and keep that validated state through every upgrade. A risk-based approach under GAMP 5 sets how much validation effort each part of the system needs.
Last updated: June 4, 2026
